About the authors
Joydeep Basu is Senior Scientist, Process Research and Assay Development, at Tengion, Inc., a clinical-stage biotechnology company which has pioneered the Autologous Organ Regeneration Platform™, which catalyzes the body’s innate ability to regenerate. Tengion has headquarters in Winston-Salem, North Carolina.
Joydeep has a BA in Natural Sciences from the University of Cambridge (UK) and a PhD in Genetics from Cornell University (Ithaca, NY). He began his industry career at Athersys, Inc. (Cleveland, OH) in 2000, where he developed and directed the human artificial chromosome program, a novel gene therapy platform for gene-based cell therapy.
In 2008 he was recruited to Tengion, Inc., where he has been involved in multiple ...